The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study
Abstract
Background —Restenosis remains an important limitation of interventional cardiology. Therefore, we aimed to determine the safety and efficacy of sirolimus (a cell-cycle inhibitor)-coated BX Velocity stents. Methods and Results —Thirty patients with angina pectoris were electively treated with 2 different formulations of sirolimus-coated stents (slow release [SR], n=15, and fast release [FR], n=15). All stents were successfully delivered, and patients were discharged without clinical complications. Independent core laboratories analyzed angiographic and 3D volumetric intravascular ultrasound data (immediately after procedure and at 4-month follow-up). Eight-month clinical follow-up was obtained for all patients. There was minimal neointimal hyperplasia in both groups (11.0±3.0% in the SR group and 10.4±3.0% in the FR group, P =NS) by ultrasound and quantitative coronary angiography (in-stent late loss, 0.09±0.3 mm [SR] and −0.02±0.3 mm [FR]; in-lesion late loss, 0.16±0.3 mm [SR] and −0.1±0.3 mm [FR]). No in-stent or edge restenosis (diameter stenosis ≥50%) was observed. No major clinical events (stent thrombosis, repeat revascularization, myocardial infarction, or death) had occurred by 8 months. Conclusions —The implantation of sirolimus-coated BX Velocity stents is feasible and safe and elicits minimal neointimal proliferation. Additional placebo-controlled trials are required to confirm these promising results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Catheter-Based Radiotherapy to Inhibit Restenosis after Coronary Stenting
Teirstein, P. S., Massullo, V., Jani, S., Popma, J. J., Mintz, G. S., Russo, R. J., Schatz, R. A., Guarneri, E. M., Steuterman, S., Morris, N. B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362402 · Cited by 942
Self-citationGroth, C. G., Bäckman, L., Morales, J.-M., Calne, R., Kreis, H., Lang, P., Touraine, J.-L., Claesson, K., Campistol, J. M., Durand, D., et al. (1999) · Transplantation · doi:10.1097/00007890-199904150-00017 · Cited by 878
van der Giessen, W. J., Lincoff, A. M., Schwartz, R. S., van Beusekom, H. M. M., Serruys, P. W., Holmes, D. R., Ellis, S. G., & Topol, E. J. (1996) · Circulation · doi:10.1161/01.cir.94.7.1690 · Cited by 852
Self-citationRapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells
Marx, S. O., Jayaraman, T., Go, L. O., & Marks, A. R. (1995) · Circulation Research · doi:10.1161/01.res.76.3.412 · Cited by 599
Rapamycin inhibits vascular smooth muscle cell migration.
Poon, M., Marx, S. O., Gallo, R., Badimon, J. J., Taubman, M. B., & Marks, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119038 · Cited by 511
Gallo, R., Padurean, A., Jayaraman, T., Marx, S., Roque, M., Adelman, S., Chesebro, J., Fallon, J., Fuster, V., Marks, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.16.2164 · Cited by 490
Late Coronary Occlusion After Intracoronary Brachytherapy
Costa, M. A., Sabaté, M., van der Giessen, W. J., Kay, I. P., Cervinka, P., Ligthart, J. M. R., Serrano, P., Coen, V. L. M. A., Levendag, P. C., & Serruys, P. W. (1999) · Circulation · doi:10.1161/01.cir.100.8.789 · Cited by 389
Self-citationFrontiers in Interventional Cardiology
Topol, E. J., & Serruys, P. W. (1998) · Circulation · doi:10.1161/01.cir.98.17.1802 · Cited by 247
Self-citationLocal drug delivery for the prevention of restenosis. Fact, fancy, and future.
Lincoff, A. M., Topol, E. J., & Ellis, S. G. (1994) · Circulation · doi:10.1161/01.cir.90.4.2070 · Cited by 171
Rapamycin Reverses Chronic Graft Vascular Disease in a Novel Cardiac Allograft Model
Poston, R. S., Billingham, M., Hoyt, E. G., Pollard, J., Shorthouse, R., Morris, R. E., & Robbins, R. C. (1999) · Circulation · doi:10.1161/01.cir.100.1.67 · Cited by 158
Cited by
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Self-citationMorice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Self-citationWRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., Mihalcsik, L., Tespili, M., Valsecchi, O., & Kolodgie, F. D. (2004) · Circulation · doi:10.1161/01.cir.0000116202.41966.d4 · Cited by 1,469
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Stimulus-responsive shape memory materials: a review
Sun, L., Huang, W. M., Ding, Z., Zhao, Y., Wang, C. C., Purnawali, H., & Tang, C. (2012) · Materials & Design · doi:10.1016/j.matdes.2011.04.065 · Cited by 1,105
Grube, E., Silber, S., Hauptmann, K. E., Mueller, R., Buellesfeld, L., Gerckens, U., & Russell, M. E. (2003) · Circulation · doi:10.1161/01.cir.0000047700.58683.a1 · Cited by 865
Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model
Suzuki, T., Kopia, G., Hayashi, S.-I., Bailey, L. R., Llanos, G., Wilensky, R., Klugherz, B. D., Papandreou, G., Narayan, P., Leon, M. B., et al. (2001) · Circulation · doi:10.1161/hc3601.093987 · Cited by 708
Self-citationSousa, J. E., Costa, M. A., Abizaid, A. C., Rensing, B. J., Abizaid, A. S., Tanajura, L. F., Kozuma, K., Van Langenhove, G., Sousa, A. G. M. R., Falotico, R., et al. (2001) · Circulation · doi:10.1161/hc4201.098056 · Cited by 672
Self-citationACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.001 · Cited by 532
Holmes, D. R., Leon, M. B., Moses, J. W., Popma, J. J., Cutlip, D., Fitzgerald, P. J., Brown, C., Fischell, T., Wong, S. C., Midei, M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000112572.57794.22 · Cited by 515
Self-citationGarg, S., & Serruys, P. W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.007 · Cited by 501
Self-citationCardiovascular Toxicities of Immunosuppressive Agents
Miller, L. W. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20902.x · Cited by 467
Fajadet, J., Wijns, W., Laarman, G.-J., Kuck, K.-H., Ormiston, J., Münzel, T., Popma, J. J., Fitzgerald, P. J., Bonan, R., & Kuntz, R. E. (2006) · Circulation · doi:10.1161/circulationaha.105.591206 · Cited by 464
Self-citationKeogh, A., Richardson, M., Ruygrok, P., Spratt, P., Galbraith, A., O’Driscoll, G., Macdonald, P., Esmore, D., Muller, D., & Faddy, S. (2004) · Circulation · doi:10.1161/01.cir.0000136812.90177.94 · Cited by 463
Bench to Bedside: The Development of Rapamycin and Its Application to Stent Restenosis
Marx, S. O., & Marks, A. R. (2001) · Circulation · doi:10.1161/01.cir.104.8.852 · Cited by 447
Duda, S. H., Pusich, B., Richter, G., Landwehr, P., Oliva, V. L., Tielbeek, A., Wiesinger, B., Hak, J. B., Tielemans, H., Ziemer, G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029746.10018.36 · Cited by 446
Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy
Mancini, D., Pinney, S., Burkhoff, D., LaManca, J., Itescu, S., Burke, E., Edwards, N., Oz, M., & Marks, A. R. (2003) · Circulation · doi:10.1161/01.cir.0000070421.38604.2b · Cited by 442
Onuma, Y., & Serruys, P. W. (2011) · Circulation · doi:10.1161/circulationaha.110.971606 · Cited by 434
Self-citationPower Approaches for Implantable Medical Devices
Amar, A., Kouki, A., & Cao, H. (2015) · Sensors · doi:10.3390/s151128889 · Cited by 432
Coronary in-stent restenosis: Current status and future strategies
Lowe, H. C., Oesterle, S. N., & Khachigian, L. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01742-9 · Cited by 414
Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction
Togni, M., Windecker, S., Cocchia, R., Wenaweser, P., Cook, S., Billinger, M., Meier, B., & Hess, O. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.062 · Cited by 373
Vascular Smooth Muscle Cell Proliferation in Restenosis
Marx, S. O., Totary-Jain, H., & Marks, A. R. (2011) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.110.957332 · Cited by 354
New Frontiers in Cardiology: Drug-Eluting Stents: Part I
Sousa, J. E., Serruys, P. W., & Costa, M. A. (2003) · Circulation · doi:10.1161/01.cir.0000069330.41022.90 · Cited by 349
Self-citationAbizaid, A., Costa, M. A., Centemero, M., Abizaid, A. S., Legrand, V. M. G., Limet, R. V., Schuler, G., Mohr, F. W., Lindeboom, W., Sousa, A. G. M. R., et al. (2001) · Circulation · doi:10.1161/hc3101.093700 · Cited by 337
Self-citationArdissino, D., Cavallini, C., Bramucci, E., Indolfi, C., Marzocchi, A., Manari, A., Angeloni, G., Carosio, G., Bonizzoni, E., Colusso, S., et al. (2004) · JAMA · doi:10.1001/jama.292.22.2727 · Cited by 314
Serruys, P. W., Garcia-Garcia, H. M., & Onuma, Y. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr384 · Cited by 303
Self-citationDrug eluting stents: are human and animal studies comparable?
Virmani, R., Kolodgie, F. D., Farb, A., & Lafont, A. (2003) · Heart · doi:10.1136/heart.89.2.133 · Cited by 300
Ten-Eleven Translocation-2 (TET2) Is a Master Regulator of Smooth Muscle Cell Plasticity
Liu, R., Jin, Y., Tang, W. H., Qin, L., Zhang, X., Tellides, G., Hwa, J., Yu, J., & Martin, K. A. (2013) · Circulation · doi:10.1161/circulationaha.113.002887 · Cited by 294
Lanza, G. M., Yu, X., Winter, P. M., Abendschein, D. R., Karukstis, K. K., Scott, M. J., Chinen, L. K., Fuhrhop, R. W., Scherrer, D. E., & Wickline, S. A. (2002) · Circulation · doi:10.1161/01.cir.0000044020.27990.32 · Cited by 287
CARTER, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.029 · Cited by 281
Rapamycin: an anti-cancer immunosuppressant?
Law, B. K. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.009 · Cited by 252
Clinical and quantitative coronary angiographic predictors of coronary restenosis
Mercado, N., Boersma, E., Wijns, W., Gersh, B. J., Morillo, C. A., de Valk, V., van Es, G.-A., Grobbee, D. E., & Serruys, P. W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01431-0 · Cited by 175
Self-citation
Metadata
- Authors
- Sousa, J. E., Costa, M. A., Abizaid, A., Abizaid, A. S., Feres, F., Pinto, I. M. F., Seixas, A. C., Staico, R., Mattos, L. A., Sousa, A. G. M. R., Falotico, R., Jaeger, J., Popma, J. J., & Serruys, P. W.
- Venue
- Circulation
- Published
- 2001-01-16
- Volume
- 103
- Issue
- 2
- Pages
- 192-195
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1998004031
- Cited by
- 793
- References
- 14
- FWCI
- 96.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.